Particle.news
Download on the App Store

CoreWeave Shares Slide After Analyst Downgrades as Funding Questions Mount

Analyst downgrades have focused attention on how CoreWeave will finance a planned $31–$35 billion 2026 buildout.

Overview

  • Shares fell about 11.4% on Friday, closing near $71.88 after Jefferies and Citigroup cut their ratings from Buy to Hold and trading volume ticked slightly below average.
  • The stock drop followed a high‑growth quarter: CoreWeave reported Q1 revenue of $2.08 billion, up 111.6% year over year, and an adjusted EPS loss of $1.40 that missed estimates.
  • Management’s 2026 capex plan of $31–$35 billion is roughly five times the company’s trailing‑12‑month revenue and has heightened investor concern over how the buildout will be funded.
  • Balance‑sheet metrics show strained short‑term liquidity and heavy leverage, with quick and current ratios near 0.31 and a debt‑to‑equity ratio around 3.7, intensifying scrutiny of financing options.
  • Insiders sold about 17.07 million shares worth roughly $1.98 billion over 90 days even as analysts remain split, leaving a Moderate Buy consensus and an average price target near $136 that underscores long‑term upside bets and short‑term execution risk.